Skip to main content
. 2023 Apr 19;13:6382. doi: 10.1038/s41598-023-33564-7

Figure 2.

Figure 2

Serum levels of TET3 and Clinical indicators. (A) When HbsAg were more than or less than 0.4 IU/mL, TET3 levels were observed between non-fibrosis, fibrosis and cirrhosis groups; (B) When AST and ALT were more than or less than 35 U/L or 40U/L, TET3 levels were observed between non-fibrosis, fibrosis and cirrhosis groups; (C) Correlation of TET3 level and clinical indicators in all patients.